Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment

▴ Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment
Arogya Sanjeevani Policy, ManipalCigna provides affordable all India health coverage also includes cover for modern treatments & procedures; hospitalisation coverage for infectious diseases like Coronavirus (Covid-19)

ManipalCigna Health Insurance Company Limited, a joint venture between Manipal Group, an eminent player in the field of healthcare delivery and higher education, U.S. based global health service leader, Cigna Corporation and Indian conglomerate TTK Group, recently announced the launch of its 'Arogya Sanjeevani Policy, ManipalCigna' in line with IRDAI's issued guidelines for a standard health cover policy. The product is specially designed to ensure that quality healthcare remains accessible and affordable to millions of people in India, especially in times when medical expenses are getting beyond everyone's reach.

'Arogya Sanjeevani Policy, ManipalCigna' is a simplified product that provides an essential health cover of Rs 1 lakh to Rs 5 lakhs for medical treatment of illnesses and injuries requiring in-patient hospitalization including for infectious diseases like Coronavirus (Covid-19) or similar such diseases and also provides cover for listed modern treatments & procedures. In addition, the product offers pre- hospitalization, post-hospitalization, AYUSH treatment, all day-care treatments, road ambulance, cumulative bonus in case of no claim and medical expenses if the insured undergoes a cataract surgery. The product also provides a family discount of 15% for covering 2 and more family members under the single individual policy to make it more affordable for families. There is an additional Online Renewal Discount of 3% p.a. from first renewal onwards, if the premium is received through NACH or Standing Instruction (where payment is made either by direct debit of bank account or credit card).

Speaking about the product launch, Prasun Sikdar, Managing Director and CEO, ManipalCigna Health Insurance Company Limited said, "Considering the growing medical inflation, and the rising infectious diseases like Coronavirus (Covid-19), having a health insurance coverage is a necessity for every individual and family. It's important for us to be prepared in advance and a safety net of health insurance coverage for yourself and family gives us protection against the medical expenses of the future. Our Arogya Sanjeevani, ManipalCigna Policy, could be a good choice for the first-time health insurance buyers in India as the policy is designed to provide access to quality health care while safeguarding your financial well-being."

Hospitalisation is a testing time for all and looking at the soaring healthcare costs, the product covers necessary hospitalization expenses incurred at any medical facility registered with ManipalCigna's network in India and even in non-network hospitals. It also covers the expenses incurred towards - dental treatment or plastic surgery necessitated due to disease or injury. Additionally, the policyholder will be provided a grace period of up to 30 days, for a yearly mode of payment. In case of a free-look period - the insured shall be allowed a period of fifteen days from date of receipt of the policy to review the terms and conditions of the policy, and to return the same if not acceptable.

Tags : #manipalcignahealthinsurance #covid-19treatment #arogyasanjeevanipolicy #moderntreatment

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024